Telework helps FDA compete for scientists. What if it’s no longer an option?

Catalyst, in collaboration with the Emily Whitehead Foundation, publishes Amplifying the Voice of CAR T-Cell Therapy Patients and Caregivers

Understanding the patient experience with CAR-T long-term follow-up (LTFU) is essential for building a sustainable model. Catalyst...

Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace

Scientific innovation in Cell & Gene Therapy (C&GT) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions

Califf: FDA will be a ‘more activist’ agency

This article describes an interview co-moderated by Catalyst CEO Nancy Myers, along with Tom Kraus, VP- Government Relations, American Society for Health-System Pharmacists. The webinar interview was sponsored by the Alliance for a Stronger FDA.